IGFBP2 promotes glioma tumor stem cell expansion and survival

David Hsieh, Antony Hsieh, Baldassarre Stea, Ron Ellsworth

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

IGFBP2 is overexpressed in the most common brain tumor, glioblastoma (GBM), and its expression is inversely correlated to GBM patient survival. Previous reports have demonstrated a role for IGFBP2 in glioma cell invasion and astrocytoma development. However, the function of IGFBP2 in the restricted, selfrenewing, and tumorigenic GBM cell population comprised of tumor-initiating stem cells has yet to be determined. Herein we demonstrate that IGFBP2 is overexpressed within the stem cell compartment of GBMs and is integral for the clonal expansion and proliferative properties of glioma stem cells (GSCs). In addition, IGFBP2 inhibition reduced Akt-dependent GSC genotoxic and drug resistance. These results suggest that IGFBP2 is a selective malignant factor that may contribute significantly to GBM pathogenesis by enriching for GSCs and mediating their survival. Given the current dearth of selective molecular targets against GSCs, we anticipate our results to be of high therapeutic relevance in combating the rapid and lethal course of GBM.

Original languageEnglish (US)
Pages (from-to)367-372
Number of pages6
JournalBiochemical and Biophysical Research Communications
Volume397
Issue number2
DOIs
StatePublished - Jun 25 2010

Fingerprint

Neoplastic Stem Cells
Glioblastoma
Stem cells
Glioma
Tumors
Cell Survival
Stem Cells
Survival
Astrocytoma
Drug Resistance
Brain Neoplasms
Brain
Cells
Population
Pharmaceutical Preparations

Keywords

  • Glioblastoma
  • IGF
  • IGFBP2
  • Tumor stem cell

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology
  • Molecular Biology

Cite this

IGFBP2 promotes glioma tumor stem cell expansion and survival. / Hsieh, David; Hsieh, Antony; Stea, Baldassarre; Ellsworth, Ron.

In: Biochemical and Biophysical Research Communications, Vol. 397, No. 2, 25.06.2010, p. 367-372.

Research output: Contribution to journalArticle

Hsieh, David ; Hsieh, Antony ; Stea, Baldassarre ; Ellsworth, Ron. / IGFBP2 promotes glioma tumor stem cell expansion and survival. In: Biochemical and Biophysical Research Communications. 2010 ; Vol. 397, No. 2. pp. 367-372.
@article{ccf018003d3c4d0e92e6b0276f1ff66f,
title = "IGFBP2 promotes glioma tumor stem cell expansion and survival",
abstract = "IGFBP2 is overexpressed in the most common brain tumor, glioblastoma (GBM), and its expression is inversely correlated to GBM patient survival. Previous reports have demonstrated a role for IGFBP2 in glioma cell invasion and astrocytoma development. However, the function of IGFBP2 in the restricted, selfrenewing, and tumorigenic GBM cell population comprised of tumor-initiating stem cells has yet to be determined. Herein we demonstrate that IGFBP2 is overexpressed within the stem cell compartment of GBMs and is integral for the clonal expansion and proliferative properties of glioma stem cells (GSCs). In addition, IGFBP2 inhibition reduced Akt-dependent GSC genotoxic and drug resistance. These results suggest that IGFBP2 is a selective malignant factor that may contribute significantly to GBM pathogenesis by enriching for GSCs and mediating their survival. Given the current dearth of selective molecular targets against GSCs, we anticipate our results to be of high therapeutic relevance in combating the rapid and lethal course of GBM.",
keywords = "Glioblastoma, IGF, IGFBP2, Tumor stem cell",
author = "David Hsieh and Antony Hsieh and Baldassarre Stea and Ron Ellsworth",
year = "2010",
month = "6",
day = "25",
doi = "10.1016/j.bbrc.2010.05.145",
language = "English (US)",
volume = "397",
pages = "367--372",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - IGFBP2 promotes glioma tumor stem cell expansion and survival

AU - Hsieh, David

AU - Hsieh, Antony

AU - Stea, Baldassarre

AU - Ellsworth, Ron

PY - 2010/6/25

Y1 - 2010/6/25

N2 - IGFBP2 is overexpressed in the most common brain tumor, glioblastoma (GBM), and its expression is inversely correlated to GBM patient survival. Previous reports have demonstrated a role for IGFBP2 in glioma cell invasion and astrocytoma development. However, the function of IGFBP2 in the restricted, selfrenewing, and tumorigenic GBM cell population comprised of tumor-initiating stem cells has yet to be determined. Herein we demonstrate that IGFBP2 is overexpressed within the stem cell compartment of GBMs and is integral for the clonal expansion and proliferative properties of glioma stem cells (GSCs). In addition, IGFBP2 inhibition reduced Akt-dependent GSC genotoxic and drug resistance. These results suggest that IGFBP2 is a selective malignant factor that may contribute significantly to GBM pathogenesis by enriching for GSCs and mediating their survival. Given the current dearth of selective molecular targets against GSCs, we anticipate our results to be of high therapeutic relevance in combating the rapid and lethal course of GBM.

AB - IGFBP2 is overexpressed in the most common brain tumor, glioblastoma (GBM), and its expression is inversely correlated to GBM patient survival. Previous reports have demonstrated a role for IGFBP2 in glioma cell invasion and astrocytoma development. However, the function of IGFBP2 in the restricted, selfrenewing, and tumorigenic GBM cell population comprised of tumor-initiating stem cells has yet to be determined. Herein we demonstrate that IGFBP2 is overexpressed within the stem cell compartment of GBMs and is integral for the clonal expansion and proliferative properties of glioma stem cells (GSCs). In addition, IGFBP2 inhibition reduced Akt-dependent GSC genotoxic and drug resistance. These results suggest that IGFBP2 is a selective malignant factor that may contribute significantly to GBM pathogenesis by enriching for GSCs and mediating their survival. Given the current dearth of selective molecular targets against GSCs, we anticipate our results to be of high therapeutic relevance in combating the rapid and lethal course of GBM.

KW - Glioblastoma

KW - IGF

KW - IGFBP2

KW - Tumor stem cell

UR - http://www.scopus.com/inward/record.url?scp=77955475753&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955475753&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2010.05.145

DO - 10.1016/j.bbrc.2010.05.145

M3 - Article

C2 - 20515648

AN - SCOPUS:77955475753

VL - 397

SP - 367

EP - 372

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 2

ER -